Global Peanut Allergy Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Peanut Allergy Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.

According to our (Global Info Research) latest study, the global Peanut Allergy Therapeutics market size was valued at US$ 981 million in 2023 and is forecast to a readjusted size of USD 8492 million by 2030 with a CAGR of 36.5% during review period.

United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.

Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.

This report is a detailed and comprehensive analysis for global Peanut Allergy Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Peanut Allergy Therapeutics market size and forecasts, in consumption value ($ Million), 2019-2030

Global Peanut Allergy Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Peanut Allergy Therapeutics market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), 2019-2030

Global Peanut Allergy Therapeutics market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Peanut Allergy Therapeutics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Peanut Allergy Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan, Bayer, UCB Pharma, J & J, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Peanut Allergy Therapeutics market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Peanut Allergy Therapeutics market is split by Type and by Distribution Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other

Market segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other

Market segment by players, this report covers
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Peanut Allergy Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Peanut Allergy Therapeutics, with revenue, gross margin, and global market share of Peanut Allergy Therapeutics from 2019 to 2024.

Chapter 3, the Peanut Allergy Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Distribution Channel, with consumption value and growth rate by Type, by Distribution Channel, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Peanut Allergy Therapeutics market forecast, by regions, by Type and by Distribution Channel, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Peanut Allergy Therapeutics.

Chapter 13, to describe Peanut Allergy Therapeutics research findings and conclusion.